Pradhan, R. ., H. Y. Yu, O. ., Platt, R. W., & Azoulay, L. . (2023). Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study. BMJ Open Diabetes Res Care, 11. http://doi.org/10.1136/bmjdrc-2023-003550
*Dipeptidyl-Peptidase IV Inhibitors/adverse effects
Pradhan, R. ., Lu, S. ., Yin, H. ., H. Y. Yu, O. ., Ernst, P. ., Suissa, S. ., & Azoulay, L. . (2022). Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study. Bmj, 379, e071380. http://doi.org/10.1136/bmj-2022-071380